# Demetrix

改造酵母过氧化物酶体以提升 β-月桂烯产量——将 β-月桂烯合酶融合与过氧化物酶体定位多拷贝整合入 Ty1 位点，增强 GPP 前体供应。

Source: https://cn.bioecon.ru/companies/demetrix/
Updated: 2026-07-08

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 获得超过6,000万美元风险融资，包括1,100万美元种子轮和5,000万美元A轮融资 | https://www.prnewswire.com/news-releases/demetrix-initiates-2022-commercial-manufacturing-campaign-301501907.html, https://www.prnewswire.com/news-releases/demetrix-secures-50-million-in-series-a-funding-to-provide-cannabinoids-to-pharmaceutical-supplement-and-consumer-product-companies-300883126.html, https://www.prnewswire.com/news-releases/demetrix-signs-its-first-contract-manufacturing-organization-for-commercial-scale-production-of-rare-cannabinoids-301232956.html |
| 产能 | 每年能够生产以公吨计的大麻素 | https://www.berkeleyside.org/2022/06/07/rare-cannabinoids-are-brewing-at-demetrix, https://www.prnewswire.com/news-releases/demetrix-signs-its-first-contract-manufacturing-organization-for-commercial-scale-production-of-rare-cannabinoids-301232956.html |
| 员工人数 | 截至2022年6月约100人 | https://www.berkeleyside.org/2022/06/07/rare-cannabinoids-are-brewing-at-demetrix |
| 生产基地 | 采用经FDA注册、符合食品cGMP标准的第三方合同生产组织（CMO）；在加州伯克利运营一个16,000平方英尺的研发中心 | https://www.berkeleyside.org/2022/06/07/rare-cannabinoids-are-brewing-at-demetrix, https://www.prnewswire.com/news-releases/demetrix-signs-its-first-contract-manufacturing-organization-for-commercial-scale-production-of-rare-cannabinoids-301232956.html |
| 营收 | 预计2022年带来数百万美元营收 [中等置信度] | https://www.prnewswire.com/news-releases/demetrix-initiates-2022-commercial-manufacturing-campaign-301501907.html |

独立来源: berkeleyside.org, prnewswire.com

## 技术

- [香精与香料的细胞工厂](https://cn.bioecon.ru/technology/cell-factories-flavors-fragrances/)